Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

ClinicalTrials.gov ID: NCT00974233

Public ClinicalTrials.gov record NCT00974233. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy With Maintenance Lenalidomide and Rituximab in Relapsed/Refractory CLL/SLL

Study identification

NCT ID
NCT00974233
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Wisconsin, Madison
Other
Enrollment
34 participants

Conditions and interventions

Interventions

  • Bendamustine Drug
  • Lenalidomide Drug
  • Rituximab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2009
Primary completion
Jun 30, 2013
Completion
Mar 31, 2015
Last update posted
Dec 1, 2019

2009 – 2015

United States locations

U.S. sites
10
U.S. states
1
U.S. cities
9
Facility City State ZIP Site status
St Vincent Regional Cancer Center Green Bay Wisconsin 54301
Bellin Memorial Hospital Green Bay Wisconsin 54313
Mercy Health System Heme/Onc Janesville Wisconsin 53548
Gundersen Clinic La Crosse Wisconsin 54601
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53792
Marshfield Clinic Marshfield Wisconsin 54449
Medical College of Wisconsin Milwaukee Wisconsin 53226
Oconomowoc Memorial Hospital Oconomowoc Wisconsin 53066
Waukesha Memorial Hospital Waukesha Wisconsin 53188
Riverview Hospital Wisconsin Rapids Wisconsin 54494

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00974233, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2019 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00974233 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →